Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-08

Clinical Trial Update: Quartet 1457Q Left Ventricular (LV) Lead Investigational Device Exemption (IDE) Study [NA]

View source ↗

Summary

The Quartet 1457Q left ventricular lead IDE study for heart failure has completed and results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Abbott Medical Devices | Conditions: Heart Failure | NA | Status: COMPLETED | Results posted: 2018-05-08